# Enzalutamide

## Xtandi 40mg

*藥物代碼*：OXTA

*給藥途徑*：O

*用法用量*：

Adult Prostate cancer, metastatic, castration-resistant: Oral: 160 mg once daily.
Concomitant use with strong CYP2C8 inhibitor: Reduce enzalutamide dose to 80 mg orally once daily; if CYP2C8 inhibitor is discontinued, return to enzalutamide dose used before initiation of CYP2C8 inhibitor.
Concomitant use with strong CYP3A4 inducer: Increase enzalutamide dose from 160 mg to 240 mg orally once daily; if CYP3A4 inducer is discontinued, return to enzalutamide dose used before initiation of CYP3A4 inducer.

